Approval · Notice of Compliance 572 · 2002
AMARYL: Notice of Compliance 572
Issued January 25, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 572
- Date
- January 25, 2002
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Oral hupoglycemic (sulfonylurea)
Products in this notice
Medicinal ingredients
- GLIMEPIRIDE 1 MG per TAB
- GLIMEPIRIDE 4 MG per TAB
- GLIMEPIRIDE 2 MG per TAB